Loading organizations...
Pappas Ventures is a specialized venture capital firm investing in innovative life science companies. It focuses on developing novel products and technologies addressing unmet medical needs across diverse human diseases. The firm provides strategic support, guiding portfolio companies from concept through commercialization in biotechnology and medical technology.
Art Pappas founded Pappas Capital approximately 32 years ago, driven by the insight that dedicated capital was essential to translate scientific discoveries into viable medical solutions. As CEO and Managing General Partner, he established the firm to nurture life science innovations in research-rich regions often overlooked by general venture funding.
Pappas Ventures' investments empower portfolio companies to deliver transformative therapies for patients globally. The firm's long-term vision is to advance breakthrough life science solutions by fostering innovation and leveraging deep industry expertise. Ultimately, Pappas Ventures strives to improve patient care and shape medicine's future.
Key people at Pappas Ventures.
Key people at Pappas Ventures.
Pappas Ventures has 20 tracked investments across 16 companies. The latest tracked deal is $58.0M Series A in VelosBio in September 2018.